139 related articles for article (PubMed ID: 8890992)
1. Rapid natriuresis and preventive hypervolaemia for symptomatic vasospasm after subarachnoid haemorrhage.
Okuchi K; Fujioka M; Fujikawa A; Nishimura A; Konobu T; Miyamoto S; Sakaki T
Acta Neurochir (Wien); 1996; 138(8):951-6; discussion 956-7. PubMed ID: 8890992
[TBL] [Abstract][Full Text] [Related]
2. Early inhibition of natriuresis suppresses symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Nakagawa I; Hironaka Y; Nishimura F; Takeshima Y; Matsuda R; Yamada S; Motoyama Y; Park YS; Nakase H
Cerebrovasc Dis; 2013; 35(2):131-7. PubMed ID: 23406891
[TBL] [Abstract][Full Text] [Related]
3. Prediction of symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage: relationship to cerebral salt wasting syndrome.
Igarashi T; Moro N; Katayama Y; Mori T; Kojima J; Kawamata T
Neurol Res; 2007 Dec; 29(8):835-41. PubMed ID: 17767804
[TBL] [Abstract][Full Text] [Related]
4. [A study of plasma atrial natriuretic peptide, antidiuretic hormone and cerebral vasospasms in patients with aneurysmal subarachnoid hemorrhage].
Morinaga K; Hayashi S; Matsumoto Y; Omiya N; Mikami J; Ueda M; Sato H; Inoue Y; Okawara S
No To Shinkei; 1993 May; 45(5):445-8. PubMed ID: 8343295
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of hyponatremia observed in the treatment of acute subarachnoid hemorrhage].
Kurokawa Y; Uede T; Honda O; Kato T
No To Shinkei; 1992 Oct; 44(10):905-11. PubMed ID: 1285991
[TBL] [Abstract][Full Text] [Related]
6. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage.
Mori T; Katayama Y; Kawamata T; Hirayama T
J Neurosurg; 1999 Dec; 91(6):947-52. PubMed ID: 10584839
[TBL] [Abstract][Full Text] [Related]
7. [Hyponatremia and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
Morinaga K; Hayashi S; Matsumoto Y; Omiya N; Mikami J; Ueda M; Sato H; Inoue Y; Okawara S
No To Shinkei; 1992 Jul; 44(7):629-32. PubMed ID: 1419338
[TBL] [Abstract][Full Text] [Related]
8. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage.
McGirt MJ; Blessing R; Nimjee SM; Friedman AH; Alexander MJ; Laskowitz DT; Lynch JR
Neurosurgery; 2004 Jun; 54(6):1369-73; discussion 1373-4. PubMed ID: 15157293
[TBL] [Abstract][Full Text] [Related]
9. Hyponatremia and natriuresis following subarachnoid hemorrhage in a monkey model.
Nelson PB; Seif S; Gutai J; Robinson AG
J Neurosurg; 1984 Feb; 60(2):233-7. PubMed ID: 6693949
[TBL] [Abstract][Full Text] [Related]
10. Volumetric quantification of Fisher Grade 3 aneurysmal subarachnoid hemorrhage: a novel method to predict symptomatic vasospasm on admission computerized tomography scans.
Friedman JA; Goerss SJ; Meyer FB; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL; Nichols DA; Atkinson JL; Wijdicks EF
J Neurosurg; 2002 Aug; 97(2):401-7. PubMed ID: 12186469
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage.
Moro N; Katayama Y; Kojima J; Mori T; Kawamata T
Stroke; 2003 Dec; 34(12):2807-11. PubMed ID: 14657545
[TBL] [Abstract][Full Text] [Related]
12. Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation.
Audibert G; Steinmann G; de Talancé N; Laurens MH; Dao P; Baumann A; Longrois D; Mertes PM
Anesth Analg; 2009 Jun; 108(6):1922-8. PubMed ID: 19448223
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.
Seiler RW; Grolimund P; Zurbruegg HR
Acta Neurochir (Wien); 1987; 85(1-2):7-16. PubMed ID: 2955675
[TBL] [Abstract][Full Text] [Related]
14. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
15. Hyponatremia is predictable in patients with aneurysmal subarachnoid hemorrhage--clinical significance of serum atrial natriuretic peptide.
Nakagawa I; Kurokawa S; Nakase H
Acta Neurochir (Wien); 2010 Dec; 152(12):2147-52. PubMed ID: 20680650
[TBL] [Abstract][Full Text] [Related]
16. Role of brain natriuretic peptide in cerebral vasospasm.
Sviri GE; Shik V; Raz B; Soustiel JF
Acta Neurochir (Wien); 2003 Oct; 145(10):851-60; discussion 860. PubMed ID: 14577006
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms.
Yamakami I; Isobe K; Yamaura A
Neurosurgery; 1987 Sep; 21(3):303-9. PubMed ID: 3670573
[TBL] [Abstract][Full Text] [Related]
18. Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage. Clinical and TCD correlations.
Sviri GE; Feinsod M; Soustiel JF
Stroke; 2000 Jan; 31(1):118-22. PubMed ID: 10625725
[TBL] [Abstract][Full Text] [Related]
19. Cerebral salt wasting in subarachnoid hemorrhage rats: model, mechanism, and tool.
Kojima J; Katayama Y; Moro N; Kawai H; Yoneko M; Mori T
Life Sci; 2005 Apr; 76(20):2361-70. PubMed ID: 15748629
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage.
Wijdicks EF; Ropper AH; Hunnicutt EJ; Richardson GS; Nathanson JA
Stroke; 1991 Dec; 22(12):1519-24. PubMed ID: 1835809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
